Home › Seizures › New Jersey
Seizures clinical trials in New Jersey
8 studies for Seizures are looking for participants at sites in New Jersey.
Cities in New Jersey
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
- Northeast Regional Epilepsy Group, Hackensack
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT07563881A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
- Neurology Center for Epilepsy and Seizures, Marlboro
RecruitingPhase 3
Ages 2 and older · All sexes · Updated Sep 15, 2026 · NCT04462770An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
- Tekton Research, Marlboro
RecruitingPhase 3
Ages 2 to 55 · All sexes · Updated Sep 15, 2026 · NCT05066217A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
- NEREG, Hackensack
- Inst of Neurology, Livingston
RecruitingPhase 2/3
Ages 18 to 75 · All sexes · Updated Aug 24, 2026 · NCT06132893A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
- Hackensack Meridian Neuroscience Institute at JFK University Medical Center, Edison
- Saint Peter's University Hospital, New Brunswick
RecruitingPhase 1
Ages 12 to 75 · All sexes · Updated Aug 11, 2026 · NCT07233239A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Northeast Regional Epilepsy Group, Hackensack
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 14, 2026 · NCT05716100Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- Northeast Regional Epilepsy Group, Hackensack
RecruitingPhase 3
Ages 4 to 55 · All sexes · Updated Jul 24, 2025 · NCT05219617An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
- Praxis Research Site, Hackensack
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Apr 3, 2025 · NCT06908356From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.